Setmelanotide in Patients Aged 2-5 Years with Rare MC4R Pathway-Associated Obesity (VENTURE): a 1 Year, Open-Label Multicenter, Phase 3 Trial
LANCET DIABETES & ENDOCRINOLOGY(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined